Follitropin Alfa is a medication commonly used in reproductive medicine to assist individuals with infertility issues. It is indicated for the stimulation of ovarian follicle development in women who are undergoing assisted reproductive techniques, such as in vitro fertilization (IVF). Follitropin Alfa helps promote the growth and maturation of multiple ovarian follicles, thereby increasing the chances of successful fertilization and pregnancy in those struggling with fertility problems.
Anovulation in fertility In Women With Proven Hypopituitarism Or Not Responded To Clomifene:
By Sc Inj:
Adults (Female): Initially Usually 75-150 Iu Daily. Monitor Response.
Superovulation treatment For Assisted Conception (such As In Vitro Fertilization):
By Sc Inj:
Adults: Usually 150-225 Iu Daily Starting On Day 2 Or 3 Of Cycle Usually 2 Wk After Starting Gnrh Agonist Treatment. Monitor Response. See Literature.
Adjunct To Hcg Therapy To Stimulate Spermatogenesis In Hypogonadotropic Hypogonadism:
By Sc Inj:
Adults (Male): 150150 Iu 3 Times A Week For A Minimum Of 4 Months. Monitor Semen Samples After 4-6 Months; Treatment For 18 Months Or More May Be Necessary.
Content
Inj 75 Iu /150 Iu /225 Iu /300 Iu: Per ml: Follicle Stimulating Hormone (fsh) 75 Iu /150 Iu /225 Iu /300 Iu, Pre-Filled Syringe, Powder In Vial Plus Amp Containing Solvent.
Pregnancy
Contraindicated In Pregnancy.
Stability
Gonadotrophin
Recombinant Human Follicle Stimulating Hormone
Contra Indications
Ovarian Cysts Or Ovarian Enlargement (not Caused By Polycystic Ovarian Syndrome), Tumours Of Breast, Tumours Of Hypothalamus, Tumours Of Ovaries, Tumours Of Pituitary, Tumours Of Prostate, Tumours Of Testes, Tumours Of Uterus, Vaginal Bleeding Of Unknown Cause
Precautions
Ovarian Cysts Or Ovarian Enlargement (not Caused By Polycystic Ovarian Syndrome), Tumours Of Breast, Tumours Of Hypothalamus, Tumours Of Ovaries, Tumours Of Pituitary, Tumours Of Prostate, Tumours Of Testes, Tumours Of Uterus, Vaginal Bleeding Of Unknown Cause